Join the Ophthalmic Surgery group to help and get support from people like you.
Ophthalmic Surgery News (Page 2)
FDA Approves Omidria for Use in Cataract and Other Intraocular Lens Replacement Procedures
SEATTLE, June 2, 2014 /PRNewswire/ – Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved Omidria (phenylephrine and ketorolac injection)...
FDA Medwatch Alert: Mobius brand Mitosol (mitomycin for solution) Kit for Ophthalmic Use: Recall-May Not be Sterile
ISSUE: Mobius Therapeutics announced that it is conducting a voluntary recall of 2 lots of Mitosol (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use. The company cannot exclude the ...
FDA Medwatch Alert: Brilliant Blue G: Recall of Unapproved Drug - Ongoing Investigation of Fungal Endophthalmitis Cases
ISSUE: FDA has received reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G (BBG) during eye surgeries. Clinicians in several states reported the adverse ...
Mobius Therapeutics Receives Final FDA Approval for New Glaucoma Drug Mitosol
ST. LOUIS, Feb. 9, 2012 /PRNewswire/ – Mobius Therapeutics, LLC, a St. Louis-based ophthalmic company, has received final approval from the U.S. Food and Drug Administration for the platform...